0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Venom Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-30W8817
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Venom Market Outlook 2022
BUY CHAPTERS

Global Anti-Venom Market Research Report 2024

Code: QYRE-Auto-30W8817
Report
January 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-Venom Market Size

The global Anti-Venom market was valued at US$ 959.2 million in 2023 and is anticipated to reach US$ 1283.7 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Anti-Venom Market

Anti-Venom Market

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
This report aims to provide a comprehensive presentation of the global market for Anti-Venom, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Venom.

Report Scope

The Anti-Venom market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Venom market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Venom manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-Venom Market Report

Report Metric Details
Report Name Anti-Venom Market
Accounted market size in 2023 US$ 959.2 million
Forecasted market size in 2030 US$ 1283.7 million
CAGR 4.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Polyvalent Anti-Venom
  • Monovalent Anti-Venom
Segment by Application
  • Non-profit Institutions
  • Hospitals and Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Venom manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Venom in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-Venom Market growing?

Ans: The Anti-Venom Market witnessing a CAGR of 4.2% during the forecast period 2024-2030.

What is the Anti-Venom Market size in 2030?

Ans: The Anti-Venom Market size in 2030 will be US$ 1283.7 million.

What is the CSL, Merck, BTG, Pfizer, Haffkine Bio Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm share in Anti-Venom Market?

Ans: CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm.

What is the Anti-Venom Market share by region?

Ans: Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume.

Who are the main players in the Anti-Venom Market report?

Ans: The main players in the Anti-Venom Market are CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm

What are the Application segmentation covered in the Anti-Venom Market report?

Ans: The Applications covered in the Anti-Venom Market report are Non-profit Institutions, Hospitals and Clinic

What are the Type segmentation covered in the Anti-Venom Market report?

Ans: The Types covered in the Anti-Venom Market report are Polyvalent Anti-Venom, Monovalent Anti-Venom

1 Anti-Venom Market Overview
1.1 Product Overview and Scope of Anti-Venom
1.2 Anti-Venom Segment by Type
1.2.1 Global Anti-Venom Market Value Comparison by Type (2024-2030)
1.2.2 Polyvalent Anti-Venom
1.2.3 Monovalent Anti-Venom
1.3 Anti-Venom Segment by Application
1.3.1 Global Anti-Venom Market Value by Application: (2024-2030)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Global Anti-Venom Market Size Estimates and Forecasts
1.4.1 Global Anti-Venom Revenue 2019-2030
1.4.2 Global Anti-Venom Sales 2019-2030
1.4.3 Global Anti-Venom Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Venom Market Competition by Manufacturers
2.1 Global Anti-Venom Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Venom Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Venom Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Venom Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Venom, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Venom, Product Type & Application
2.7 Anti-Venom Market Competitive Situation and Trends
2.7.1 Anti-Venom Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Venom Players Market Share by Revenue
2.7.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Venom Retrospective Market Scenario by Region
3.1 Global Anti-Venom Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Venom Global Anti-Venom Sales by Region: 2019-2030
3.2.1 Global Anti-Venom Sales by Region: 2019-2024
3.2.2 Global Anti-Venom Sales by Region: 2025-2030
3.3 Global Anti-Venom Global Anti-Venom Revenue by Region: 2019-2030
3.3.1 Global Anti-Venom Revenue by Region: 2019-2024
3.3.2 Global Anti-Venom Revenue by Region: 2025-2030
3.4 North America Anti-Venom Market Facts & Figures by Country
3.4.1 North America Anti-Venom Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Venom Sales by Country (2019-2030)
3.4.3 North America Anti-Venom Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Venom Market Facts & Figures by Country
3.5.1 Europe Anti-Venom Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Venom Sales by Country (2019-2030)
3.5.3 Europe Anti-Venom Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Venom Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Venom Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Venom Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Venom Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Venom Market Facts & Figures by Country
3.7.1 Latin America Anti-Venom Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Venom Sales by Country (2019-2030)
3.7.3 Latin America Anti-Venom Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Venom Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Venom Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Venom Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Venom Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Venom Sales by Type (2019-2030)
4.1.1 Global Anti-Venom Sales by Type (2019-2024)
4.1.2 Global Anti-Venom Sales by Type (2025-2030)
4.1.3 Global Anti-Venom Sales Market Share by Type (2019-2030)
4.2 Global Anti-Venom Revenue by Type (2019-2030)
4.2.1 Global Anti-Venom Revenue by Type (2019-2024)
4.2.2 Global Anti-Venom Revenue by Type (2025-2030)
4.2.3 Global Anti-Venom Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Venom Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Venom Sales by Application (2019-2030)
5.1.1 Global Anti-Venom Sales by Application (2019-2024)
5.1.2 Global Anti-Venom Sales by Application (2025-2030)
5.1.3 Global Anti-Venom Sales Market Share by Application (2019-2030)
5.2 Global Anti-Venom Revenue by Application (2019-2030)
5.2.1 Global Anti-Venom Revenue by Application (2019-2024)
5.2.2 Global Anti-Venom Revenue by Application (2025-2030)
5.2.3 Global Anti-Venom Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Venom Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Anti-Venom Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Anti-Venom Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BTG Anti-Venom Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Anti-Venom Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Description and Business Overview
6.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Rare Disease Therapeutics Anti-Venom Product Portfolio
6.6.5 Rare Disease Therapeutics Recent Developments/Updates
6.7 Flynn Pharma
6.6.1 Flynn Pharma Corporation Information
6.6.2 Flynn Pharma Description and Business Overview
6.6.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Flynn Pharma Anti-Venom Product Portfolio
6.7.5 Flynn Pharma Recent Developments/Updates
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Description and Business Overview
6.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vins Bioproducts Anti-Venom Product Portfolio
6.8.5 Vins Bioproducts Recent Developments/Updates
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Description and Business Overview
6.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bharat Serums and Vaccines Anti-Venom Product Portfolio
6.9.5 Bharat Serums and Vaccines Recent Developments/Updates
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Description and Business Overview
6.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Serum Biotech Anti-Venom Product Portfolio
6.10.5 Serum Biotech Recent Developments/Updates
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Anti-Venom Description and Business Overview
6.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MicroPharm Anti-Venom Product Portfolio
6.11.5 MicroPharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Venom Industry Chain Analysis
7.2 Anti-Venom Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Venom Production Mode & Process
7.4 Anti-Venom Sales and Marketing
7.4.1 Anti-Venom Sales Channels
7.4.2 Anti-Venom Distributors
7.5 Anti-Venom Customers
8 Anti-Venom Market Dynamics
8.1 Anti-Venom Industry Trends
8.2 Anti-Venom Market Drivers
8.3 Anti-Venom Market Challenges
8.4 Anti-Venom Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Anti-Venom Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anti-Venom Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anti-Venom Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anti-Venom Sales (K Vials) of Key Manufacturers (2019-2024)
    Table 5. Global Anti-Venom Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anti-Venom Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anti-Venom Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anti-Venom Average Price (USD/Vial) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anti-Venom, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anti-Venom, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anti-Venom, Product Type & Application
    Table 12. Global Key Manufacturers of Anti-Venom, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-Venom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-Venom Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anti-Venom Sales by Region (2019-2024) & (K Vials)
    Table 18. Global Anti-Venom Sales Market Share by Region (2019-2024)
    Table 19. Global Anti-Venom Sales by Region (2025-2030) & (K Vials)
    Table 20. Global Anti-Venom Sales Market Share by Region (2025-2030)
    Table 21. Global Anti-Venom Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anti-Venom Revenue Market Share by Region (2019-2024)
    Table 23. Global Anti-Venom Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anti-Venom Revenue Market Share by Region (2025-2030)
    Table 25. North America Anti-Venom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anti-Venom Sales by Country (2019-2024) & (K Vials)
    Table 27. North America Anti-Venom Sales by Country (2025-2030) & (K Vials)
    Table 28. North America Anti-Venom Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anti-Venom Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anti-Venom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anti-Venom Sales by Country (2019-2024) & (K Vials)
    Table 32. Europe Anti-Venom Sales by Country (2025-2030) & (K Vials)
    Table 33. Europe Anti-Venom Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anti-Venom Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anti-Venom Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anti-Venom Sales by Region (2019-2024) & (K Vials)
    Table 37. Asia Pacific Anti-Venom Sales by Region (2025-2030) & (K Vials)
    Table 38. Asia Pacific Anti-Venom Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anti-Venom Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anti-Venom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anti-Venom Sales by Country (2019-2024) & (K Vials)
    Table 42. Latin America Anti-Venom Sales by Country (2025-2030) & (K Vials)
    Table 43. Latin America Anti-Venom Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anti-Venom Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anti-Venom Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anti-Venom Sales by Country (2019-2024) & (K Vials)
    Table 47. Middle East & Africa Anti-Venom Sales by Country (2025-2030) & (K Vials)
    Table 48. Middle East & Africa Anti-Venom Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anti-Venom Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anti-Venom Sales (K Vials) by Type (2019-2024)
    Table 51. Global Anti-Venom Sales (K Vials) by Type (2025-2030)
    Table 52. Global Anti-Venom Sales Market Share by Type (2019-2024)
    Table 53. Global Anti-Venom Sales Market Share by Type (2025-2030)
    Table 54. Global Anti-Venom Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anti-Venom Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anti-Venom Revenue Market Share by Type (2019-2024)
    Table 57. Global Anti-Venom Revenue Market Share by Type (2025-2030)
    Table 58. Global Anti-Venom Price (USD/Vial) by Type (2019-2024)
    Table 59. Global Anti-Venom Price (USD/Vial) by Type (2025-2030)
    Table 60. Global Anti-Venom Sales (K Vials) by Application (2019-2024)
    Table 61. Global Anti-Venom Sales (K Vials) by Application (2025-2030)
    Table 62. Global Anti-Venom Sales Market Share by Application (2019-2024)
    Table 63. Global Anti-Venom Sales Market Share by Application (2025-2030)
    Table 64. Global Anti-Venom Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anti-Venom Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anti-Venom Revenue Market Share by Application (2019-2024)
    Table 67. Global Anti-Venom Revenue Market Share by Application (2025-2030)
    Table 68. Global Anti-Venom Price (USD/Vial) by Application (2019-2024)
    Table 69. Global Anti-Venom Price (USD/Vial) by Application (2025-2030)
    Table 70. CSL Corporation Information
    Table 71. CSL Description and Business Overview
    Table 72. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 73. CSL Anti-Venom Product
    Table 74. CSL Recent Developments/Updates
    Table 75. Merck Corporation Information
    Table 76. Merck Description and Business Overview
    Table 77. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 78. Merck Anti-Venom Product
    Table 79. Merck Recent Developments/Updates
    Table 80. BTG Corporation Information
    Table 81. BTG Description and Business Overview
    Table 82. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 83. BTG Anti-Venom Product
    Table 84. BTG Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 88. Pfizer Anti-Venom Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Haffkine Bio-Pharmaceutical Corporation Information
    Table 91. Haffkine Bio-Pharmaceutical Description and Business Overview
    Table 92. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 93. Haffkine Bio-Pharmaceutical Anti-Venom Product
    Table 94. Haffkine Bio-Pharmaceutical Recent Developments/Updates
    Table 95. Rare Disease Therapeutics Corporation Information
    Table 96. Rare Disease Therapeutics Description and Business Overview
    Table 97. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 98. Rare Disease Therapeutics Anti-Venom Product
    Table 99. Rare Disease Therapeutics Recent Developments/Updates
    Table 100. Flynn Pharma Corporation Information
    Table 101. Flynn Pharma Description and Business Overview
    Table 102. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 103. Flynn Pharma Anti-Venom Product
    Table 104. Flynn Pharma Recent Developments/Updates
    Table 105. Vins Bioproducts Corporation Information
    Table 106. Vins Bioproducts Description and Business Overview
    Table 107. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 108. Vins Bioproducts Anti-Venom Product
    Table 109. Vins Bioproducts Recent Developments/Updates
    Table 110. Bharat Serums and Vaccines Corporation Information
    Table 111. Bharat Serums and Vaccines Description and Business Overview
    Table 112. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 113. Bharat Serums and Vaccines Anti-Venom Product
    Table 114. Bharat Serums and Vaccines Recent Developments/Updates
    Table 115. Serum Biotech Corporation Information
    Table 116. Serum Biotech Description and Business Overview
    Table 117. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 118. Serum Biotech Anti-Venom Product
    Table 119. Serum Biotech Recent Developments/Updates
    Table 120. MicroPharm Corporation Information
    Table 121. MicroPharm Description and Business Overview
    Table 122. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
    Table 123. MicroPharm Anti-Venom Product
    Table 124. MicroPharm Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Anti-Venom Distributors List
    Table 128. Anti-Venom Customers List
    Table 129. Anti-Venom Market Trends
    Table 130. Anti-Venom Market Drivers
    Table 131. Anti-Venom Market Challenges
    Table 132. Anti-Venom Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-Venom
    Figure 2. Global Anti-Venom Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anti-Venom Market Share by Type in 2023 & 2030
    Figure 4. Polyvalent Anti-Venom Product Picture
    Figure 5. Monovalent Anti-Venom Product Picture
    Figure 6. Global Anti-Venom Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Anti-Venom Market Share by Application in 2023 & 2030
    Figure 8. Non-profit Institutions
    Figure 9. Hospitals and Clinic
    Figure 10. Global Anti-Venom Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Anti-Venom Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Anti-Venom Sales (2019-2030) & (K Vials)
    Figure 13. Global Anti-Venom Average Price (USD/Vial) & (2019-2030)
    Figure 14. Anti-Venom Report Years Considered
    Figure 15. Anti-Venom Sales Share by Manufacturers in 2023
    Figure 16. Global Anti-Venom Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Anti-Venom Players: Market Share by Revenue in 2023
    Figure 18. Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Anti-Venom Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Anti-Venom Sales Market Share by Country (2019-2030)
    Figure 21. North America Anti-Venom Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Anti-Venom Sales Market Share by Country (2019-2030)
    Figure 25. Europe Anti-Venom Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Anti-Venom Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Anti-Venom Revenue Market Share by Region (2019-2030)
    Figure 33. China Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Anti-Venom Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Anti-Venom Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Anti-Venom Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Anti-Venom Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Anti-Venom Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Anti-Venom by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Anti-Venom by Type (2019-2030)
    Figure 55. Global Anti-Venom Price (USD/Vial) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Anti-Venom by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Anti-Venom by Application (2019-2030)
    Figure 58. Global Anti-Venom Price (USD/Vial) by Application (2019-2030)
    Figure 59. Anti-Venom Value Chain
    Figure 60. Anti-Venom Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Anti-Anxiety Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Q7423
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Real-Time Thermal Cyclers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39X13417
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Actarit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q7887
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Bepotastine Besilate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14X7647
Fri Feb 23 00:00:00 UTC 2024

Add to Cart